Quest Diagnostics, Inc. (DGX)
230.44
-2.19
(-0.94%)
USD |
NYSE |
Oct 13, 16:00
230.44
0.00 (0.00%)
After-Hours: 20:00
Quest Diagnostics Cash from Investing (Quarterly) : -134.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -134.00M |
| March 31, 2026 | -152.00M |
| December 31, 2025 | -191.00M |
| September 30, 2025 | -201.00M |
| June 30, 2025 | -124.00M |
| March 31, 2025 | -115.00M |
| December 31, 2024 | -502.00M |
| September 30, 2024 | -1.633B |
| June 30, 2024 | -200.00M |
| March 31, 2024 | -213.00M |
| December 31, 2023 | -114.00M |
| September 30, 2023 | -107.00M |
| June 30, 2023 | -682.00M |
| March 31, 2023 | -158.00M |
| December 31, 2022 | -174.00M |
| September 30, 2022 | -118.00M |
| June 30, 2022 | -82.00M |
| March 31, 2022 | -169.00M |
| December 31, 2021 | -227.00M |
| September 30, 2021 | -96.00M |
| June 30, 2021 | 437.00M |
| March 31, 2021 | -93.00M |
| December 31, 2020 | -168.00M |
| September 30, 2020 | -193.00M |
| June 30, 2020 | -205.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -206.00M |
| December 31, 2019 | -100.00M |
| September 30, 2019 | -109.00M |
| June 30, 2019 | -92.00M |
| March 31, 2019 | -110.00M |
| December 31, 2018 | -342.00M |
| September 30, 2018 | -117.00M |
| June 30, 2018 | -124.00M |
| March 31, 2018 | -202.00M |
| December 31, 2017 | -362.00M |
| September 30, 2017 | -247.00M |
| June 30, 2017 | -170.00M |
| March 31, 2017 | -47.00M |
| December 31, 2016 | -107.00M |
| September 30, 2016 | -72.00M |
| June 30, 2016 | 217.00M |
| March 31, 2016 | -190.00M |
| December 31, 2015 | -113.00M |
| September 30, 2015 | -63.00M |
| June 30, 2015 | -68.00M |
| March 31, 2015 | -55.00M |
| December 31, 2014 | -91.00M |
| September 30, 2014 | -93.00M |
| June 30, 2014 | -205.00M |
| March 31, 2014 | -636.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | -366.20M |
| DaVita, Inc. | -194.55M |
| OPKO Health, Inc. | 15.54M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -8.319M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 597.00M |
| Cash from Financing (Quarterly) | -229.00M |
| Free Cash Flow | 1.349B |
| Free Cash Flow Per Share (Quarterly) | 4.098 |
| Free Cash Flow to Equity (Quarterly) | 482.00M |
| Free Cash Flow to Firm (Quarterly) | 495.17M |
| Free Cash Flow Yield | 5.22% |